Construction and application of microneedle-mediated photothermal therapy and immunotherapy combined anti-tumor drug delivery system

Drug Deliv. 2023 Dec;30(1):2232950. doi: 10.1080/10717544.2023.2232950.

Abstract

Conventional treatments for tumors were frequently accompanied by drawbacks and side effects. It might be useful to use the revolutionary microneedle technology which combines photothermal therapy with tumor immunotherapy. In this study, we created a microneedle drug delivery system with mercapto-modified gold nanorods and immune checkpoint blocker anti-PD-1 polypeptide. With good mechanical strength, the microneedle system can efficiently penetrate the skin and deliver drugs. When inserted into human skin, anti-PD-1 peptides and gold nanorods can be released, boosting the capacity of cytotoxic T lymphocytes to destroy tumor cells. Additionally, the elimination of the tumor is aided by the production of heat while being exposed to near-infrared light. This microneedle drug delivery system can enhance the immunological reaction and prolong the survival time of mice. Moreover, it has been demonstrated that the system has mild toxic and side effects on normal tissues and can effectively inhibit the growth of tumors, indicating a bright prospect for the treatment of cancers.

Keywords: Cancer immunotherapy; dissolving microneedles; photothermal therapy; transcutaneous immunization.

MeSH terms

  • Animals
  • Antineoplastic Agents*
  • Drug Delivery Systems
  • Drug-Related Side Effects and Adverse Reactions*
  • Gold
  • Humans
  • Immunotherapy
  • Mice
  • Photothermal Therapy

Substances

  • Antineoplastic Agents
  • Gold

Grants and funding

This work was supported by the National Natural Science Foundation of China [12104400]; the Major Scientific and Technological Innovation Projects of Wenzhou [ZY2021026]; the 2021 Open Project from Zhejiang Key Laboratory of Quality Control of Pharmaceutical Contact Materials [ZJYJ2021062301].